BMO reiterates Buy for Welltower stock at USD 265.00 target

Published on 10/02/2026 at 17:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 3.54 billion in the second quarter of 2026. Welltower stock costs EUR 202.75 versus EUR 201.38 on October 2, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte US95040Q1040 und Stethoskop für Welltower Inc — Welltower Inc. (US95040Q1040) Anlageobjekt symbolisiert durch Aktienzertifikat, ISIN-Karte und medizinische Utensilien im Flatlay, Illustration mit AI erstellt.

Welltower Inc. (ISIN US95040Q1040) was trading at EUR 202.75 at Lang & Schwarz on October 2, 2026 at 5:02 p.m. CEST, up 0.68 percent versus the prior close of EUR 201.38. Markets Insider reported on October 1, 2026 that BMO Capital analyst Juan C. Sanabria reiterated a Buy rating and set a USD 265.00 price target.

BMO keeps its USD 265 target

The target places BMO's assessment above the current US-dollar market quotation, but the euro reference price and the dollar target use different currencies and are not combined into one upside calculation. The rating therefore adds a dated analyst view without changing the Lang & Schwarz reference price used for Welltower stock.

The latest reported quarter also gives the valuation debate a concrete operating anchor. According to Markets Insider on October 1, 2026, Welltower reported USD 3.54 billion in revenue and USD 240.29 million in net profit for the quarter ending June 30, 2026. The same report said revenue was USD 3.54 billion versus USD 2.52 billion a year earlier, while net profit was USD 240.29 million versus USD 301.89 million.

Revenue growth meets an earnings miss

MarketBeat reported on September 24, 2026 that JPMorgan upgraded Welltower from neutral to overweight and set a USD 260.00 target. MarketBeat also reported adjusted earnings per share of USD 0.61 for the second quarter of 2026 against a USD 0.66 consensus estimate, a USD 0.05 shortfall, while revenue exceeded the USD 3.40 billion estimate.

That contrast matters for the next catalyst: revenue growth supports the operating story, but the earnings-per-share miss leaves execution and profitability central to the analyst case. The company has also set the next reporting date. According to StockTitan on September 23, 2026, Welltower will release third-quarter 2026 results after the NYSE close on October 26, 2026, followed by a conference call on October 27, 2026 at 9:00 a.m. ET.

Stock stays below its yearly high

Welltower's USD 164.6 billion market capitalization and USD 163.75 to USD 255.20 52-week range, both as of October 2, 2026, frame the stock's current level. The Lang & Schwarz quote remains the relevant euro measure for investors in Germany, while the NYSE listing supplies the company's primary market context.

Welltower's portfolio centers on healthcare-related real estate, including seniors housing, post-acute communities and outpatient medical facilities. The company operates as a real estate investment trust and is listed on the NYSE under the ticker WELL, according to the company's corporate information.

October earnings set the next test

The next scheduled report will put the second-quarter combination of USD 3.54 billion revenue and USD 0.61 adjusted earnings per share into a new period of comparison. Until then, the dated analyst targets of USD 260.00 and USD 265.00 provide context, while the euro quote stood at EUR 202.75 versus EUR 201.38 at Lang & Schwarz on October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Welltower stock.